Lichuang Men Selected Research

Tyrosine Kinase Inhibitors

1/2023	Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
10/2022	Correction: Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
1/2022	Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lichuang Men Research Topics

Disease

3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 01/2022
2	Neoplasms (Cancer) 11/2023 - 01/2017
1	Stomach Neoplasms (Stomach Cancer) 11/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2023
1	Tumor Lysis Syndrome 01/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Type 2 Diabetes Mellitus (MODY) 04/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2017

Drug/Important Bio-Agent (IBA)

3	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2022
3	olverembatinibIBA 01/2023 - 01/2022
1	pelcitoclaxIBA 11/2023
1	CaspasesIBA 11/2023
1	LisaftoclaxIBA 01/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2018
1	Insulin (Novolin)FDA Link 04/2018
1	Insulin Glargine (Lantus)FDA Link 04/2018
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2017
1	BilirubinIBA 01/2017
1	Leucovorin (Folinic Acid)FDA Link 01/2017
1	Fluorouracil (Carac)FDA LinkGeneric 01/2017
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017

Therapy/Procedure

1	Glycemic Control 04/2018